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School-age children are frequently at high risk for the onset of biofilm-dependent 
conditions, including dental caries and periodontal diseases. The objective of this study 
was to evaluate the clinical efficacy of a dentifrice containing Eugenia uniflora Linn. 
(Surinam cherry) extract versus a triclosan-based comparator in treating gingivitis 
in children aged 10-12 years. The in vitro antibacterial potential of the dentifrice 
was tested against oral pathogens (Streptococcus mutans, Streptococcus oralis and 
Lactobacillus casei). Then a phase-II clinical trial was conducted with 50 subjects aged 
10-12 years, with clinical signs of gingivitis. The subjects were randomly assigned to the 
experimental group (n=25) and control group (n=25), in which participants used the 
experimental dentifrice and a triclosan-based fluoridated dentifrice (Colgate Total 12®), 
respectively. Clinical examinations assessed the presence of gingivitis (primary outcome) 
and biofilm accumulation (secondary outcome) using the Gingival-Bleeding Index (GBI) 
and Simplified Oral Hygiene Index (OHI-S), respectively, at baseline and after seven days 
of tooth brushing 3x/day. The data were analyzed using paired and unpaired t-test (GBI) 
and Wilcoxon and Mann-Whitney (OHI-S), with p≤0.05. The experimental dentifrice 
showed efficient antibacterial activity in vitro. In the clinical trial, a significant reduction 
in gingival bleeding was observed in both experimental and control groups (p<0.0001), 
with no statistical difference between them (p=0.178), although a small size effect was 
observed. Biofilm accumulation was only reduced in the control group (p=0.0039). In 
conclusion, E. uniflora dentifrice showed anti-gingivitis properties in children aged 10-12 
years. Thus, it may be a potentially efficient and safe product to be used alternatively in 
preventive dental practice
Eugenia uniflora Dentifrice for Treating 
Gingivitis in Children: Antibacterial 
Assay and Randomized Clinical Trial
Vanessa de Carvalho Jovito1, Irlan Almeida Freires2, Danilo Augusto de 
Holanda Ferreira1, Marçal de Queiroz Paulo3, Ricardo Dias de Castro4
1Center for Health Sciences, 
UFPB - Universidade Federal da 
Paraíba, João Pessoa, PB, Brazil
2Department of Physiological 
Sciences, Piracicaba Dental School, 
UNICAMP - Universidade Estadual 
de Campinas, Piracicaba, SP, Brazil
3Department of Chemistry, Center 
for Exact Sciences and Nature, 
UFPB - Universidade Federal da 
Paraíba, João Pessoa, PB, Brazil
4Department of Speech Therapy, 
UFPB - Universidade Federal da 
Paraíba, João Pessoa, PB, Brazil
Correspondence: Ricardo Dias de 
Castro, Rua Barão Adalto Lucio, 24, 
58051-900 João Pessoa, PB, Brasil. 
Tel: +55-83-3216-7877. e-mail: 
ricardodiasdecastro@yahoo.com.br
Key Words: gingivitis, 
dentifrice, biofilm, Eugenia 
uniflora, Surinam cherry.
Introduction 
Gingivitis is the most prevalent condition affecting 
the periodontium in pediatric patients (1,2). This highly 
prevalent disease among children and young adults results 
from the interplay between bacterial virulence factors and 
the host’s limited defense capacity (3). 
Even developed countries have shown high prevalence 
and incidence rates of periodontal disease (4). This 
epidemiological status quo requires the adoption of 
measures to address this public health issue by educational, 
preventive and therapeutic actions. This background 
encourages the use of alternative therapies for oral health 
care, particularly in communities with limited access to 
health services (4). Natural products have shown to be 
potential therapeutic resources for treating oral diseases, 
especially of infectious nature, such as dental caries (5) 
and candidiasis (6), and of inflammatory origin, such as 
gingivitis (7).
Based on its common medicinal use, this research group 
and others have explored the pharmacological potential 
of Eugenia uniflora L. extracts, which is also known as 
Surinam cherry. Extracts from the leaves, stems and fruits 
were recognized for their promising antimicrobial and 
anti-inflammatory activities (8-10). Furthermore, this plant 
can be found in several countries because it adapts easily 
to different weather and soil conditions (9). 
Previous studies have investigated the toxicity potential 
of E. uniflora L. extract and confirmed that it is safe for 
clinical use (11). Moreover, the ripe fruit (used in the present 
study) is edible and there are no reports of adverse effects 
related to its use. 
Therefore, the wide distribution of E. uniflora in South 
America, the proven biological properties and presence of 
bioactive chemical compounds (mainly sesquiterpenes) (8-
10), the negligible toxicity of its fruits (11), and finally the 
potential development of an effective, low-cost dentifrice 
for economically disadvantaged communities – at least 
comparable to the ones available in the market – have 
encouraged us to develop an E. uniflora experimental 
dentifrice. Herein, this study investigated the in vitro 
antibacterial activity and short-term clinical efficacy of 
this dentifrice containing E. uniflora L. extract versus 
a triclosan-based comparator in treating gingivitis and 
biofilm accumulation in children.
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Material and Methods
The present study was conducted in two stages: (i) in 
vitro evaluation of the antibacterial activity of E. uniflora 
L. dentifrice against oral pathogens; and (ii) phase II 
clinical trial of the experimental dentifrice in subjects 
with gingivitis.
The hydroalcoholic extract of E. uniflora ripe fruit and 
the pharmaceutical formulation of the dentifrice were 
performed at the Natural Products Chemistry Laboratory of 
the Federal University of Paraiba. Each 10 mL of E. uniflora L. 
dentifrice comprises the following components as described 
by Jovito et al. (8): hydroalcoholic extract of the ripe fruit 
of E. uniflora L. (3.0%), preservatives (parabenes, 0.02 g), 
and dentifrice base (silicon dioxide, sodium lauryl sulfate, 
white dye, aromatic compounds, sodium saccharin and 
Gangrez sodium salt; q.s.p.).
In Vitro Phase: Evaluation of Antimicrobial 
Activity
The in vitro minimum inhibitory concentration (MIC) 
of the dentifrices was determined by the agar diffusion 
technique described by Bauer (12). Serial dilutions of the 
experimental and control dentifrice (Colgate Total 12®) 
were prepared at concentrations ranging from 0.3 g/mL to 
0.005 g/mL. The latter was used as a positive control due to 
its known antibacterial and anti-inflammatory activities. 
Briefly, 3 g of dentifrice was dissolved in 10 mL of sterile 
distilled water, yielding a solution that was subsequently 
centrifuged at 5,000 rpm for 10 min to precipitate the solid 
particles. After centrifugation, the supernatant obtained 
from each dentifrice was used for the antibacterial assay. 
Streptococcus mutans (ATCC 25175), Streptococcus 
oralis (ATCC 10557), and Lactobacillus casei (ATCC 7469) 
strains were tested in the present study. The inoculum was 
adjusted according to the 0.5 tube of McFarland standard, 
which corresponds to approximately 1.5 x 108 CFU/mL. The 
bacterial suspensions were seeded onto agar plates and 
well-shaped 6-mm perforations were made in the solid 
culture medium afterwards. Samples of 50 µL of dentifrice 
supernatant at different concentrations were inserted in 
the wells. The plates were incubated at 37 ºC and 5% CO2 
for 24 h. The MIC was defined as the lowest concentration 
of the dentifrice that inhibited visible bacterial growth.
Phase II Clinical Trial
Study Design 
After the antibacterial activity of the experimental 
dentifrice was confirmed in vitro, was carried out the 
phase II: a randomized, controlled, double-blind clinical 
trial comparing the experimental and control dentifrices. 
The study had a parallel design and investigated the 
short-term clinical efficacy of Surinam cherry dentifrice 
against gingivitis and biofilm accumulation). The CONSORT 
guidelines were followed to design this investigation.
Study Participants
Eligibility criteria were used to select a homogenous 
sample to participate in the clinical trial. As inclusion 
criteria, were selected children of both sexes aged 10 to 12 
years, with presence of at least 15 teeth, showing biofilm-
induced gingivitis and whose participation was consented 
by their parents/legal guardians. Excluded subjects were 
those with systemic conditions that could interfere with 
periodontal health; wearers of fixed/removable orthodontic 
appliances; mouthrinse users or subjected to topical fluoride 
application in the previous three months; and undergoing 
treatment with antimicrobials or anti-inflammatory drugs. 
All subjects were recruited at a public school in the city 
of João Pessoa, PB, Brazil, where their examinations were 
carried out and one of the three daily tooth-brushings was 
supervised (directly).
The sample size was estimated using Fleming’s single-
stage procedure for phase II trials (13). With regard to the 
primary outcome, a response proportion of at least 50% 
was defined as being clinically significant. The type I error 
was set as 0.05, and the type II error was set at 0.1. Based 
on these values, a sample size of 20 individuals per trial 
arm would provide 90% power (1-β) to detect any clinically 
relevant treatment difference of 50% or greater compared 
to baseline. Taking into consideration an attrition rate of 
approximately 20%, the final sample size per trial arm 
comprised 25 individuals.
Randomization
After meeting the eligibility criteria, subjects were 
number-coded and their allocation into the experimental 
or control group was determined by drawing lots with 
replacement. Allocation data were concealed by a single 
researcher, who did not examine the subjects, in a sealed 
envelope during the whole performance of the study.
Blinding
The experimental and control dentifrices were kept in 
similar containers, and had the same color (white), taste 
(mint) and smell (mint). Thus, neither the participants nor 
the examiners were aware of the allocated interventions, 
characterizing the study as double-blinded.
Control
A commercially available dentifrice containing 1500 
ppm fluoride and 0.3% triclosan (Colgate Total 12®, 
Colgate-Palmolive Company) was used as control due to 
its known effects against gingivitis and plaque formation. 
Braz Dent J 27(4) 2016
389
 E
ug
en
ia
 u
ni
flo
ra
 e
xp
er
im
en
ta
l d
en
ti
fr
ic
e
Subjects allocated to the control group followed the same 
procedures as those of the experimental group.
Intra-Examiner Agreement
The examination of subjects concerning the study 
outcome indices was performed by a single examiner who 
was adequately calibrated with a Kappa statistic of 0.8, 
which is considered to be satisfactory agreement, according 
to Landis & Koch (14).
Intervention Protocol
The experimental group comprised 25 subjects who used 
the dentifrice with E. uniflora L. ripe fruit hydroalcoholic 
extract, three times per day, for seven consecutive days. The 
control group comprised 25 subjects who used the control 
dentifrice (fluoride, 1500 ppm and triclosan, 0.3%), three 
times per day, for seven consecutive days. The participants 
(and their parents) were instructed as to the number of three 
daily brushings and one of them was supervised at school 
by the researchers. They were also instructed concerning 
the pea-sized amount of dentifrice to be used. An active 
personal and telephonic contact was established with the 
parents in order to assure protocol compliance.
Primary and Secondary Outcomes of Interest
Clinical examinations were performed at baseline and 
after seven days of dentifrice use. The examination data 
were recorded in a specific clinical chart. The diagnosis of 
gingivitis (primary outcome) was established by bleeding on 
probing using the Gingival Bleeding Index (GBI) proposed 
by Ainamo and Bay (15). The accumulation of biofilm 
(secondary outcome) was assessed with the Simplified Oral 
Hygiene Index (OHI-S) described by Greene and Vermilion 
(16). Prior to the study, all subjects were instructed on 
correct tooth brushing techniques and received a kit that 
contained a toothbrush and one of the dentifrices (without 
the identification of its contents).
Ethical and Regulatory Aspects
The present study was approved by the Ethics Research 
Committee of the João Pessoa University Center (Centro 
Universitário de João Pessoa, UNIPÊ), João Pessoa, 
PB, Brazil. The parents/legal guardians of each of the 
participating children signed a detailed informed consent 
form to authorize their participation. The study followed 
the guidelines of the 466/12 Resolution of the Brazilian 
National Health Council, which encompasses the Helsinki 
Declaration. Moreover, the clinical trial was registered at 
ClinicalTrials.gov under protocol NCT02648139.
Statistical Analysis
The data were analyzed on GraphPad Prism version 
5.0 statistical software (GraphPad Software, Inc., La Jolla, 
CA, USA). Intra- and intergroup comparisons at baseline 
and post-interventions were performed using paired t 
and unpaired t tests (for GBI data) and Wilcoxon signed-
rank test and Mann-Whitney test (for S-OHI data), with a 
significance level of 5%. 
Results
Table 1 shows the results of the in vitro antibacterial 
activity of the dentifrices against oral microorganisms. The 
MIC of both the experimental and control dentifrices was 
5 mg/mL against all bacterial strains, except for E. uniflora 
dentifrice against S. mutans, which was 9.3 mg/mL.
All participants completed the phase II clinical trial, 
therefore with no loss of follow-up. Regarding the 
experimental and control arms, 32% and 52% of the sample 
were males, respectively, and 68% and 48% females. The 
median number of teeth was 24 in the experimental group 
and 26 in the control group. The baseline levels of gingival 
inflammation and biofilm accumulation were not different 
between groups (p>0.05), thus characterizing a clinically 
homogenous sample. 
As seen in Table 2, the study findings demonstrated that 
both the experimental and control dentifrices significantly 
reduced the levels of gingival bleeding as compared to 
baseline (p<0.0001). The means of differences between 
baseline and post-intervention data showed no significant 
difference in the effectiveness of Surinam cherry dentifrice 
and the triclosan-based comparator (p=0.178), although 
a small size effect was observed. Table 3 shows the effect 
of the dentifrices in reducing biofilm accumulation after 
seven days of dentifrice use. It may be clearly seen that 
Table 1. Evaluation of the Minimum Inhibitory Concentration (MIC) of 
the experimental and control dentifrices against Streptococcus mutans 
ATCC 25175, Streptococcus oralis ATCC 10557 and Lactobacillus casei 
ATCC 7469. The zones of inhibition are expressed in millimeters (mm)
Sample 
concentration
Inhibition zone (mm)
S. mutans S. oralis L. casei
SC Ctrl SC Ctrl SC Ctrl
0.3 g/mL 14.0 18.0 23 30 26 20
0.15 g/mL 12.0 14.0 19 29 25 19
0.075 g/mL 11.0 12.0 15 25 19 15
0.0375 g/mL 10.0 11.0 15 24 18 13
0.01875 g/mL 7.0 10.0 15 15 18 12
0.009375 g/mL 7.0 9.5 14 14 18 12
0.005 g/mL 0.0 9.0 14 13 18 11
Note: SC, Surinam cherry experimental dentifrice; Ctrl, control 
dentifrice (Colgate Total 12®).
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only the triclosan-based dentifrice was able to reduce 
the accumulation of dental biofilm during this period 
(p=0.0039) (Table 3). No adverse effects were reported or 
clinically identified during examinations.
Discussion
In dentistry, there has been an increase in the use 
of medicinal plants and molecules extracted from 
natural products for the preparation of products with 
pharmacological properties. Nevertheless, many gaps 
remain in the experimental design and analytical 
methodology used in most studies, which makes it difficult 
to translate in vitro findings into efficient and safe clinical 
use (5,6). The present study aimed to contribute to the 
development of an effective and low cost formulation 
that improves oral health by promoting the ecological and 
biochemical balance of the oral cavity.
The Brazilian Ministry of Health recently released a 
list of plants with the aim of guiding research to evaluate 
whether they may be used by the public health system. E. 
uniflora L. (Surinam cherry), which has antimicrobial activity 
against bacteria present in oral biofilm that cause caries 
and periodontal diseases, was one of the listed species (8,9). 
These data support the findings of this study, in which the 
experimental dentifrice exhibited in vitro antibacterial 
activity against streptococci and lactobacilli. As expected, 
the conducted study also confirmed the antimicrobial 
potential of the control dentifrice containing triclosan, 
which is a chemical agent recognized in literature as having 
antimicrobial properties (17). 
The choice to include S. mutans, S. oralis, and L. casei 
strains was because they are part of the normal oral biofilm 
microbiota and participate in either the initial (S. oralis 
and S. mutans) or advanced (L. casei) colonization process 
of the microbial community (18-20). Because gingival 
inflammation results from the initial colonization of the 
dental surface by these microorganisms, it is necessary to 
disrupt microbial colonization to avoid microbial growth 
and establishment of periodontal pathogenic bacteria 
responsible for advanced periodontal disease (20,21). 
The observed reduction in gingival bleeding produced 
by the dentifrice containing the hydroalcoholic extract 
from E. uniflora ripe fruit suggests that the product has the 
potential to prevent and/or treat gingivitis. In a previous 
study conducted by this research group, this dentifrice 
also reduced gingivitis in a sample of 40 undergraduate 
students between 21 and 24 years of age, following 22 
consecutive days of dentifrice use (8). 
There was no significant reduction in OHI-S post-
intervention scores, which measure tooth surface biofilm 
accumulation, as compared to baseline in the experimental 
group. This finding may be due to the following reasons: 
Table 2. Mean Gingival Bleeding Index (GBI) values (±SD) for the experimental (Surinam cherry dentifrice) and control (Triclosan-based dentifrice) 
groups at baseline and after 7-day treatment. 95% confidence interval values are expressed in brackets
Gingival 
Bleeding Index
Baseline
(B)
Post-intervention
(PI)
Mean of differences 
between (B) and (PI)
Effect size*
Intra-group 
difference†
Inter-group 
difference#
Surinam cherry 
dentifrice
3.45 ± 1.80 
[2.704 to 4.192]
1.13 ± 1.48
[0.522 to 1.749]
2.32 ± 1.11
[1.856 to 2.769] 0.396 
[-0.163 to 0.956]
P<0.0001
P= 0.178
Triclosan-based 
dentifrice
2.974 ± 1.15
[2.499 to 3.450]
1.10 ± 0.91
[0.724 to 1.479]
1.87 ± 1.16
[1.393 to 2.354]
P<0.0001
*The effect size for GBI was calculated based on the mean of differences between (B) and (PI) and standard deviation. †Intra-group comparisons 
before and after intervention (paired-t test, p≤0.05). #Comparisons of the mean of differences (4th column) between the groups Surinam cherry 
vs. Triclosan-based dentifrice (unpaired-t test, p≤0.05).
Table 3. Median Simplified Oral Hygiene Index (S-OHI) values (plus inter-quartile range) for the experimental (Surinam cherry dentifrice) and 
control (triclosan-based dentifrice) groups at baseline and after 7-day treatment. Minimum and maximum interquartile range is presented in 
parenthesis and 95% confidence interval values are expressed in brackets
Simplified Oral 
Hygiene Index
Baseline
(B)
Post-intervention
(PI)
Sum of ranks 
of differences 
between (B) 
and (PI) ¥
Effect size*
Intra-group 
difference†
Inter-group 
difference#
Surinam cherry 
dentifrice
1.16 (0.75)
[1.075 to 1.607]
1.16 (0.33)
[0.982 to 1.411]
714
0.386
[-0.173 to 0.945]
P=0.1006
P=0.139
Triclosan-based 
dentifrice
1.33 (0.34)
[1.206 to 1.513]
1.16 (0.58)
[0.922 to 1.190] 
561 P=0.0039
¥Mann-Whitney U: 236. *The effect size for S-OHI was calculated based on median values and interquartile range. †Intra-group comparisons 
before and after intervention (Wilcoxon signed-rank test, p≤0.05); #Comparisons of the sum of ranks of differences (4th column) between the 
groups Surinam cherry vs. triclosan-based dentifrice (Mann-Whitney test, p≤0.05).
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low abrasive potential of the dentifrice, resulting in 
poor mechanical removal of biofilm; or a low in vivo 
concentration, which may have not been enough to produce 
the same effects observed in vitro, due to salivary clearance, 
substantivity and other factors inherent to the human body. 
In contrast, the control dentifrice was efficient in reducing 
biofilm accumulation, which corroborates previous studies 
that evaluated the potential of triclosan-based dentifrices 
(17,22-24). 
The ripe fruit of E. uniflora contains flavonoids, which 
are chemical markers of anti-inflammatory activity. The 
activity of the experimental dentifrice active component 
may be directly associated with certain pathways of the 
inflammatory process because there was a reduction in 
gingival bleeding but not in biofilm accumulation (25). 
Similarly, Soares (10) conducted an in vivo evaluation 
of a mouthwash containing the hydroalcoholic extract of 
E. uniflora ripe fruit in individuals wearing orthodontic 
braces. The author observed a statistically significant 
reduction in gingival bleeding based on the GBI (p<0.05) 
and in bacterial counts for S. mutans (p<0.01), but not in 
biofilm accumulation based on the OHI-S (p>0.05) before 
(baseline) and after (post-intervention, 15 days) dentifrice 
use. These findings could also be explained by the anti-
inflammatory activities of E. uniflora.
The results of the present study suggest the need for 
additional clinical trials focusing on the anti-inflammatory 
potential of E. uniflora. Although no adverse effects were 
reported by research subjects, it is important to investigate 
the long-term clinical and toxicological effects of the 
experimental dentifrice. 
Furthermore, the need for pharmaceutical technological 
support should be stressed for formulating a dentifrice 
with satisfactory physical and chemical properties. In 
particular, certain aspects of the dentifrice: color, taste 
and abrasiveness require improvement. 
This study demonstrated that the dentifrice containing 
the hydroalcoholic ripe fruit extract of E. uniflora L. 
(Surinam cherry) showed anti-gingivitis properties in 
children aged 10 to 12 years. E. uniflora dentifrice may 
be a potentially efficient and safe product to be used 
alternatively in preventive dental practice.
Resumo
Crianças em idade escolar apresentam, com frequência, alto risco para 
o desenvolvimento de doenças biofilme-dependentes, incluindo cárie 
e doenças periodontais. Este estudo investigou a eficácia clínica de 
um dentifrício contendo o extrato de Eugenia uniflora Linn. (pitanga) 
comparado a um dentifrício com triclosan no combate à gengivite em 
crianças de 10 a 12 anos. Foi avaliado o potencial antibacteriano in 
vitro do dentifrício sobre microorganismos da cavidade oral (S. mutans 
S. oralis and L. casei) e realizado um estudo clínico fase II incluindo 50 
sujeitos, com sinais clínicos de gengivite, divididos aleatoriamente em 
dois grupos: Experimental – 25 sujeitos usaram o dentifrício contendo 
extrato de pitanga; e Controle – 25 sujeitos que usaram um dentifrício 
fluoretado contendo triclosan (Colgate Total 12®). Na baseline e após 
sete dias consecutivos de escovação, foi realizado o exame clínico para 
diagnóstico de gengivite (desfecho primário) e acúmulo de biofilme 
(desfecho secundário), utilizando o Índice de Sangramento Gengival (ISG) 
e Índice de Higiene Oral Simplificado (IHO-S). Os dados foram analisados 
utilizando o teste t pareado e não pareado (ISG) e teste de Wilcoxon e 
Mann-Whitney (IHO-S), com nível de significância de p≤0,05. Observou-
se uma efetiva atividade antibacteriana do dentifrício experimental. No 
estudo clínico, observou-se redução de sangramento gengival em ambos 
os grupos experimental e controle (p<0,0001), não havendo diferença 
entre eles (p 0,178), embora com uma pequena magnitude de efeito. 
Apenas o grupo controle reduziu significantemente o acúmulo de biofilme 
(p=0,0039). Concluiu-se que o dentifrício experimental de E. uniflora 
mostrou-se eficaz na redução de gengivite em crianças de 10 a 12 anos. 
Assim, este dentifrício apresenta potencial para ser utilizado de forma 
eficaz e segura em odontologia preventiva.
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